Neuroprosthetics Market Growth As Increasing Number of Patients Suffering From Neurological Disorders and Nerve Injury During 2017-22
Neuroprosthetic devices are used to develop or supplant the central nervous system’s function, when embedded in the human body, in order to stimulate organ function that was previously incomplete due to a disease or injury. The global neuroprosthetics market is expected to reach USD 10.48 billion by 2022 from USD 5.84 billion in 2017, at a CAGR of 12.4%.
Download Free Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=234147399
Globally,...
High Prevalence of Infectious Diseases and Various Types of Cancers– A Key Factor Driving The Market for Molecular Diagnostics
The global molecular diagnostics market is projected to reach USD 11.54 billion by 2023 from USD 7.71 billion in 2018, at CAGR of 8.4%. Growth in this market is driven by the high prevalence of infectious diseases and various types of cancers, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market, and advancements in molecular...
Patient Monitoring Device/System/Equipment Market expected to reach USD 25.31 Billion by 2023, at a CAGR of 5.7%, over 2017–2023
The patient monitoring devices market is expected to reach USD 25.31 billion by 2023 from USD 19.14 billion in 2018, at a CAGR of 5.7%. Factors such as the easy availability of wireless monitoring devices and the rising incidence of lifestyle and chronic diseases are expected to drive market growth during the forecast period. On the other hand, the risks associated with invasive monitoring devices...
Favorable Regulations Driving the Use of Biological Safety Cabinets in the Healthcare Industry
The biological safety cabinets market is projected to reach USD 205.9 million by 2022 from USD 144.3 million in 2017, at a CAGR of 7.4% during the forecast period.
Growth in the biological safety cabinets market is mainly driven by factors such as favorable regulations, increased risk of pandemics and communicable diseases, increasing number of R&D activities in biotechnological and pharmaceutical...
Specimen Validity Testing Market is Primarily Driven by The Growth in Drug Screening Market And Increase in Workplace Drug Testing
The global specimen validity testing market is projected to reach USD 1.49 billion by 2023 from USD 1.10 billion in 2018, at a CAGR of 6.3%. The growth of the specimen validity testing market is primarily driven by the growth in the drug screening market and increase in workplace drug testing.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=147024121
The specimen validity...
Neuroscience Antibodies & Assays Market : Rising Incidence of Neurological Diseases
The global neuroscience antibodies and assays market is expected to reach USD 4.18 billion by 2023 from USD 2.57 billion in 2018, at a CAGR of 10.2%. Growth in this market is driven by the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries. On the other hand, quality and cost concerns over the production...
Immunoassay Market | Increasing Adoption of Immunoassay-Based Point-Of-Care Testing and Rapid Testing
The immunoassays market is expected to reach USD 27.15 billion by 2023 from USD 20.19 billion in 2018, at a CAGR of 6.1%. Factors driving the growth of this market include the increasing adoption of immunoassay-based point-of-care (POC) testing and rising incidence of chronic diseases across the world.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=436
The global immunoassays...
Biomarker Technologies Market : Increasing Utility of Biomarkers for Diagnostic Purposes And Rising Biomarker Research
The global biomarker technologies market was valued at USD 46.97 billion in 2017. It is expected to reach USD 74.51 billion in 2022, at CAGR of 9.7% during the forecast period.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=190358765
The growth of this market is mainly driven by increasing healthcare expenditure, rising R&D funding, the increasing utility of biomarkers...
Growing Adoption of Open Innovation Models Dominating High Throughput Screening Market
The global high-throughput screening (HTS) market is projected to reach USD 21.69 billion by 2023 from USD 14.87 billion in 2018, at a CAGR of 7.8%. Factors such initiatives undertaken by pharmaceutical and biotechnology companies, increasing R&D spending, technological advancements in HTS, and the availability of government funding and venture capital investments are driving the growth of the...
Reducing Cost of Sequencing and Growing Volume of Data Generated During Sequencing Driving Bioinformatics Services Market
The global bioinformatics services market is projected to reach USD 3.53 billion by 2023 from USD 1.70 billion in 2018, at a CAGR of 15.7%. Factors such as growing applications of bioinformatics in various industries, increasing public-private sector funding for bioinformatics services, and the shortage of skilled bioinformatics professionals leading to increased outsourcing of bioinformatics projects...